Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2005
12/01/2005WO2005100285A3 Novel alkyne compounds exhibiting an mch antagonistic effect and drugs containing said compounds
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005WO2005048933A3 Oxime substituted imidazo ring compounds
12/01/2005WO2004085401A8 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267148 Benzimidazole derivative
12/01/2005US20050267146 3-(4-Heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/01/2005US20050267137 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
12/01/2005US20050267131 Treatment of HIV integrase heterocycles for enzyme inhibitors and process of viricides
12/01/2005US20050267130 e.g. 2,3,4,5-tetrahydro-2-[2-[4-methoxy-7-(5-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-5-phenyl-1H-pyrido[4,3-b]indole; inhibit HIV entry by attaching to exterior viral envelop protein gp120 and interrupting viral entry process by interfering with cellular receptor CD4
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050267116 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
12/01/2005US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005US20050267100 For therapy of obesity
12/01/2005US20050267097 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
12/01/2005US20050266024 Adjuvant
12/01/2005DE102004022383A1 New pyridopyrazine derivatives are modulators of kinase activity, useful for the treatment of diseases associated with abnormal cellular signaling, e.g. tumors
12/01/2005DE102004021716A1 Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen Substituted imidazo [1,2-a] pyridine compounds and pharmaceutical compositions containing substituted imidazo [1,2-a] pyridine compounds
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2566755A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
12/01/2005CA2566387A1 Aryl sulfonamides as chemokine receptor ccr9 antagonists
12/01/2005CA2566074A1 Azinyl imidazoazine and azinyl carboxamide
11/2005
11/30/2005EP1600159A1 A method for synthesizing different Zolpidem hemitartrate derivatives
11/30/2005EP1599476A1 Novel diazabicyclic aryl derivatives
11/30/2005EP1599475A2 Jnk inhibitors
11/30/2005EP1599474A2 Alternative heterocycles for dna recognition
11/30/2005EP1599473A1 Imidazo 4,5-b quinoline-derivatives and their use as no-synthase inhibitors
11/30/2005EP1599465A1 Substituted n-aryl nitrogen heterocycles
11/30/2005EP1599447A1 Ligands that modulate lxr-type receptors
11/30/2005EP1599206A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
11/30/2005EP1599203A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments
11/30/2005EP1465892A4 Glycinamides as factor xa inhibitors
11/30/2005EP1432708B1 Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity
11/30/2005EP1313740B1 Prodrugs of imidazopyridine derivatives
11/30/2005EP1224185B1 Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use
11/30/2005CN1703414A Novel imidazopyridines as cyclin dependent kinase inhibitors
11/30/2005CN1703412A Novel compounds with antibacterial activity
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703400A Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/30/2005CN1229382C Hemisynthetic method and intermediate thereof
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229376C 1,7-disubstituted perylene-3,4,9.10-tetracarboxylic acid diimide, its preparation and use
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/29/2005US6969722 Amide substituted imidazopyridines
11/29/2005US6969721 Tricyclic 2-pyridone compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005CA2420329C Sulphonylaminocarbonyltriazolinones
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/29/2005CA2244245C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/24/2005WO2005111047A1 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
11/24/2005WO2005111044A1 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
11/24/2005WO2005111042A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005111038A2 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
11/24/2005WO2005111037A1 Beta-carbolines useful for treating inflammatory disease
11/24/2005WO2005111036A1 Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands
11/24/2005WO2005111035A1 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents
11/24/2005WO2005111034A1 5-substituted 1-phenyl-1,5-dihydro-pyrido’3,2-b! indol-2-ones and analogs as anti-virals
11/24/2005WO2005111030A1 Quinolone antibacterial agents
11/24/2005WO2005111022A1 Pyrimidines derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111018A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
11/24/2005WO2005111004A1 Novel sustained-action bronchodilating agents for use in the treatment of respiratory diseases
11/24/2005WO2005111001A1 Novel fused heterocycles and uses thereof
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110989A1 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
11/24/2005WO2005110986A1 Hydroformylation process for pharmaceutical intermediate
11/24/2005WO2005110982A2 Substituted 1-benzyl-4-substituted piperazine analogues
11/24/2005WO2005110416A2 4,5-disubstituted-2-aryl pyrimidines
11/24/2005WO2005110410A2 Kinase inhibitors as therapeutic agents
11/24/2005WO2005110409A2 Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity
11/24/2005US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia
11/24/2005US20050261333 Inhibitors of the kinase Itk; 2-aryl-substituted derivatives of 6-substituted-3H-imidazo[4,5-b]pyridines; to treat allergic, autoimmune, inflammatory, proliferative and hyperproliferative diseases and immune-mediated diseases; 6,7-dichloro-2-[4-(2-morpholin-4-ylethoxy)phenyl]-3H-imidazo[4,5-b]pyridine
11/24/2005US20050261332 Sulfonamides and uses thereof
11/24/2005US20050261331 Substituted pyrrolopyridines
11/24/2005US20050261323 Medical uses of novel carbamate-substituted pyrazolopyridine derivatives
11/24/2005US20050261322 HIV integrase inhibitors
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261311 Piperizinones as modulators of chemokine receptor activity
11/24/2005US20050261310 Piperazinylpiperidine derivatives as chemokine receptor antagonists
11/24/2005US20050261309 Imidazole compounds
11/24/2005US20050261306 Anti-neurodegenerative agents
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261296 Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
11/24/2005US20050261290 Novel compounds of proline and morpholine derivatives
11/24/2005US20050261288 Tetracyclic lactam derivatives and uses thereof
11/24/2005US20050261287 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
11/24/2005US20050261272 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
11/24/2005US20050261244 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005DE102004022672A1 Substituierte Azachinazoline Substituted Azachinazoline
11/24/2005DE102004020570A1 Substituierte Phenylaminopyrimidine Substituted Phenylaminopyrimidine
11/24/2005CA2566332A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005CA2566158A1 Kinase inhibitors as therapeutic agents
11/24/2005CA2565984A1 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 646